1. | ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group: 1 article (01/2022) |
1. | amubarvimab
|
2. | Monoclonal Antibodies
|
3. | sotrovimab
|
4. | Neutralizing Antibodies
|
5. | Proteins (Proteins, Gene)
|
6. | Immunoglobulin G (IgG)
|
1. | Therapeutics
|